Jatin Patel

584 total citations
19 papers, 362 citations indexed

About

Jatin Patel is a scholar working on Immunology, Epidemiology and Rheumatology. According to data from OpenAlex, Jatin Patel has authored 19 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Epidemiology and 7 papers in Rheumatology. Recurrent topics in Jatin Patel's work include Inflammatory Bowel Disease (5 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and Microscopic Colitis (4 papers). Jatin Patel is often cited by papers focused on Inflammatory Bowel Disease (5 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and Microscopic Colitis (4 papers). Jatin Patel collaborates with scholars based in United Kingdom, United States and Netherlands. Jatin Patel's co-authors include Mary Fewtrell, James V. Leonard, Philip Lee, Nicholas Bishop, Michael Binks, Phebe Wilson, C.E.M. Griffiths, Joanna Watson, Kristian Reich and Valerie J. Ludbrook and has published in prestigious journals such as Gastroenterology, Journal of Allergy and Clinical Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Jatin Patel

19 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jatin Patel United Kingdom 12 150 131 87 72 71 19 362
Amandine Charras United Kingdom 10 140 0.9× 160 1.2× 73 0.8× 46 0.6× 24 0.3× 29 395
S. John United Kingdom 8 118 0.8× 159 1.2× 57 0.7× 23 0.3× 66 0.9× 15 350
Paola Cagnati Italy 10 93 0.6× 174 1.3× 21 0.2× 76 1.1× 51 0.7× 11 436
Iván Posso‐Osorio Colombia 11 150 1.0× 112 0.9× 48 0.6× 41 0.6× 28 0.4× 55 326
SE Marshall United Kingdom 10 44 0.3× 207 1.6× 124 1.4× 63 0.9× 51 0.7× 12 461
K Mitamura Japan 11 75 0.5× 138 1.1× 63 0.7× 52 0.7× 38 0.5× 19 340
Xunyao Wu China 12 143 1.0× 196 1.5× 24 0.3× 54 0.8× 88 1.2× 26 474
Marco Di Battista Italy 11 86 0.6× 66 0.5× 32 0.4× 55 0.8× 55 0.8× 42 342
Cathryn Anne Scott Italy 11 57 0.4× 56 0.4× 35 0.4× 84 1.2× 34 0.5× 27 320
O. Fogel France 8 71 0.5× 74 0.6× 37 0.4× 62 0.9× 14 0.2× 21 267

Countries citing papers authored by Jatin Patel

Since Specialization
Citations

This map shows the geographic impact of Jatin Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jatin Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jatin Patel more than expected).

Fields of papers citing papers by Jatin Patel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jatin Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jatin Patel. The network helps show where Jatin Patel may publish in the future.

Co-authorship network of co-authors of Jatin Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Jatin Patel. A scholar is included among the top collaborators of Jatin Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jatin Patel. Jatin Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Buckley, Christopher D., Jesus Abraham Simón Campos, Вячеслав Миколайович Ждан, et al.. (2020). Efficacy, patient-reported outcomes, and safety of the anti-granulocyte macrophage colony-stimulating factor antibody otilimab (GSK3196165) in patients with rheumatoid arthritis: a randomised, phase 2b, dose-ranging study. The Lancet Rheumatology. 2(11). e677–e688. 24 indexed citations
2.
Genovese, Mark C., Philip G. Conaghan, Charles Peterfy, et al.. (2020). MRI of the joint and evaluation of the granulocyte–macrophage colony-stimulating factor–CCL17 axis in patients with rheumatoid arthritis receiving otilimab: a phase 2a randomised mechanistic study. The Lancet Rheumatology. 2(11). e666–e676. 15 indexed citations
3.
Schett, Georg, L.C. Bainbridge, Katherine Davy, et al.. (2020). Anti-granulocyte-macrophage colony-stimulating factor antibody otilimab in patients with hand osteoarthritis: a phase 2a randomised trial. The Lancet Rheumatology. 2(10). e623–e632. 16 indexed citations
4.
Buckley, Christopher D., Jesus Abraham Simón Campos, Вячеслав Миколайович Ждан, et al.. (2019). OP0228 GSK3196165 AN INVESTIGATIONAL ANTI-GM-CSF MONOCLONAL ANTIBODY, IMPROVES PATIENT REPORTED OUTCOMES IN A PHASE IIB STUDY OF PATIENTS WITH RHEUMATOID ARTHRITIS (RA). Annals of the Rheumatic Diseases. 78. 191–191. 4 indexed citations
5.
Shukla, Akash, et al.. (2018). Budd–Chiari syndrome has different presentations and disease severity during adolescence. Hepatology International. 12(6). 560–566. 16 indexed citations
6.
Shukla, Akash, et al.. (2017). Cirrhotic cardiomyopathy is less prevalent in patients with Budd-Chiari syndrome than cirrhosis of liver. Indian Journal of Gastroenterology. 36(6). 474–480. 4 indexed citations
7.
Ludbrook, Valerie J., Jatin Patel, Michael Binks, et al.. (2016). Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study. British Journal of Dermatology. 174(5). 985–995. 66 indexed citations
8.
Patel, Jatin, et al.. (2016). Homocysteine level in Coronary artery disease patients of Ahmedabad population. International Journal of Medical Science and Public Health. 6(3). 1–1. 1 indexed citations
9.
Patel, Jatin, et al.. (2015). Uncommon presentation of Strongyloidiasis. Tropical Gastroenterology. 36(3). 212–215. 1 indexed citations
10.
Patel, Jatin, et al.. (2014). Comparison of Four Models for End-Stage Liver Disease–Based Prognostic Systems for Cirrhosis. Clinical Gastroenterology and Hepatology. 13(1). 215–215. 1 indexed citations
11.
Wechsler, Michael E., Patricia C. Fulkerson, Bruce S. Bochner, et al.. (2012). Novel targeted therapies for eosinophilic disorders. Journal of Allergy and Clinical Immunology. 130(3). 563–571. 77 indexed citations
12.
Mamula, Petar, Stanley A. Cohen, George D. Ferry, et al.. (2004). CDP571, a Humanized Anti-Tumor Necrosis Factor-α Monoclonal Antibody in Pediatric Crohn’s Disease. Inflammatory Bowel Diseases. 10(6). 723–730. 13 indexed citations
13.
Serruys, Patrick W., et al.. (2003). Effect of an anti‐PDGF‐β‐receptor‐blocking antibody on restenosis in patients undergoing elective stent placement. PubMed. 5(4). 214–222. 16 indexed citations
14.
15.
Winter, Trevor A., John Wright, Subrata Ghosh, Jørgen Jahnsen, & Jatin Patel. (2003). Intravenous CDP870, a humanized anti-TNF antibody fragment, in patients with active Crohn's diseaseȁAn exploratory study. Gastroenterology. 124(4). A377–A377. 8 indexed citations
16.
Schreiber, Stefan, et al.. (2003). CDP870, a humanized anti-TNF antibody fragment, induces clinical response with remission in patients with active Crohn's disease (CD). Gastroenterology. 124(4). A61–A61. 32 indexed citations
17.
Sandborn, William J., Brian Feagan, Graham Radford-Smith, et al.. (2003). A randomized, placebo-controlled trial of CDP571, a humanized monoclonal antibody to TNF-α, in patients with moderate to severe Crohn's disease. Gastroenterology. 124(4). A61–A61. 20 indexed citations
18.
Lee, Philip, Jatin Patel, Mary Fewtrell, James V. Leonard, & Nicholas Bishop. (1995). Bone mineralisation in type 1 glycogen storage disease. European Journal of Pediatrics. 154(6). 483–487. 35 indexed citations
19.
Lee, Philip, et al.. (1995). Bone mineralisation in type 1 glycogen storage disease. European Journal of Pediatrics. 154(6). 483–487. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amandine Charras Breakdown of academic impact, for papers by S. John Breakdown of academic impact, for papers by Paola Cagnati Breakdown of academic impact, for papers by Iván Posso‐Osorio Breakdown of academic impact, for papers by SE Marshall Breakdown of academic impact, for papers by K Mitamura Breakdown of academic impact, for papers by Xunyao Wu Breakdown of academic impact, for papers by Marco Di Battista Breakdown of academic impact, for papers by Cathryn Anne Scott Breakdown of academic impact, for papers by O. Fogel
Rankless by CCL
2026